Canopy Growth (CGC) Asset Utilization Ratio (2020 - 2026)
Canopy Growth (CGC) posted Asset Utilization Ratio of 0.39 for Q4 2025, up 39.65% sequentially from 0.28 in Q3 2025, and up 67.97% YoY from 0.23 in Q4 2024.
Canopy Growth (CGC) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Canopy Growth has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.39 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 67.97% year-over-year to 0.39 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.39 (up 67.97% YoY) and the FY2026 annual result came in at 0.06, up 44.36% from the prior year.
- Asset Utilization Ratio improved to 0.39 in Q4 2025 per CGC's latest filing, from 0.28 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.39 in Q4 2025 and troughed at 0.02 in Q4 2022.
- A 5-year average of 0.15 and a median of 0.16 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio sank 124.0% in 2022, then soared 4726.67% in 2023.
- Over 5 years, Asset Utilization Ratio stood at 0.09 in 2021, then slumped by 124.0% to 0.02 in 2022, then jumped by 1145.79% to 0.22 in 2023, then grew by 3.46% to 0.23 in 2024, then jumped by 67.97% to 0.39 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.39, 0.28, and 0.31 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | 0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.42 |
| Dec 31, 2025 | 0.39 |
| Sep 30, 2025 | 0.28 |
| Jun 30, 2025 | 0.31 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | 0.22 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | 0.22 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.09 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.06 |
| Mar 31, 2021 | 0.06 |